Research studies dating back almost forty years had shown that irritating reconstructive solutions cause dilation of blood vessels and a migration of fibroblasts (healing cells) to the injured areas. These healing cells lay down collagen (a structural protein) to repair the area.

  In a study conducted in the 1950s by surgeon George Hackett, M.D., 1,600 patients with severe sacroiliac sprain were treated with reconstructive injections. When the patients were examined by independent physicians two to twelve years later, 82 percent had remained free of pain or recurrences. Dr. Hackett's experiments were repeated in 1983 and 1985 by the University of Iowa's Department of Orthopedic Research. Both studies found that the patients' tendons became more firmly attached to the bone and increased in strength and structure by 30 to 40 percent above normal.

  In 1987, at the Sansum Medical Clinic of Santa Barbara, California, rheumatologist Robert Klein, M.D., and internist Thomas Dorman, M.D., conducted a double-blind study of eighty-one patients who suffered from continuous low back pain for more than ten years. They found that 88 percent of the patients injected with a reconstructive solution of dextrose, glycerine, and phenol demonstrated moderate to marked improvement. A similar study, reported in the Journal of Spinal Disorders, showed an 80 percent improvement. Both studies support Dr. Hackett's findings.

  Studies conducted by Harold Walmer, D.O., of Elizabeth, Pennsylvania, have also shown that reconstructive therapy increases mechanical strength in ligaments and joints. This may explain why so many patients with advanced degeneration of bones and soft tissues, or those who suffer from a wide range of musculoskeletal problems, have improved so dramatically when given reconstructive injections.